Replies to post #5279 on First China Pharmaceutical Group Inc (fka FCPG)

[lanx]

I agree with you Hoo. Allowing runaway costs with cash flow still being tight (especially in growth mode) would be a catastrophe and could result in a cheaper buyout based on necessity rather than strength. Growth is huge but cash is king. They have to demonstrate their plan works top and bottom.